Pilot study for TS-1 for the prevention of ectopic metachronous esophageal cancer after endoscopic resection(S-1 adjuvant)
Not Applicable
- Conditions
- The patient with high grade multiple lugol voiding lesion(mLVL)s after endoscopic resection for early stage esophageal cancer
- Registration Number
- JPRN-UMIN000015571
- Lead Sponsor
- Graduate School of Medicine, Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients requiring for additional surgery or chemoradiotherapy for curatively treated with local therapy 2)Patients requiring chmotherapy or had chemothrapy past 6 months 3)Patients had irradiation of esophagus 4)Patients requiring Flucytosine administration 5)Patients requiring warfarine administration 6)Patients for allergy of iodine 7)Positive HBs antigen 8)Pregnancy, possible pregnancy after delivery or breastfeeding 9)Patients had complicating critical disease 10)Active infection requiring systemic therapy 11)contraindication for TS-1 12)Patients whom a researcher judges to be inappropriate as a subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion for improvement the grade of mLVLs
- Secondary Outcome Measures
Name Time Method The cumulative incidence rate, the proportion for adverse event